“…Plasma elimination half-lives of misonidazole in our patients receiving anticonvulsant therapy ranged between 4.1 and 8.9 h with a mean value of 6.2 h, which was comparable with the half-life values between 5.4 and 7.9 h reported earlier in similar patients (Workman et al , 1980;Williams et al, 1983;Matheson et al, 1984). Metabolic induction of misonidazole could be important, as administration of phenytoin and phenobarbitone might be associated with a reduced neurotoxicity of misonidazole in man (Moore et al, 1981;Williams et al, 1983). In one of our patients with brain glioma (C19) without anticonvulsant therapy a plasma elimination half-life of misonidazole of 9.5 h was measured, which is in agreement with a mean half-life of 10-12 h normally found in patients not enzymically induced Workman et al , 1978).…”